Which diagnostic test should be ordered to evaluate for nephrolithiasis in a 74-year-old woman?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 26, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Diagnostic Testing for Kidney Stones in a 74-Year-Old Female

Order ultrasound as the initial imaging test, followed by low-dose non-contrast CT if ultrasound is inconclusive or if detailed stone characterization is needed for treatment planning.

Primary Diagnostic Approach

The 2025 European Association of Urology guidelines establish ultrasound as the primary diagnostic tool for suspected nephrolithiasis 1. This recommendation is particularly appropriate for a 74-year-old woman given radiation exposure concerns in older adults who may require repeated imaging over time.

Ultrasound Performance Characteristics

  • Sensitivity: 45% for detecting stones
  • Specificity: 94% for ureteral stones and 88% for renal stones 1
  • Should include both grayscale and color Doppler to assess for "twinkling artifact" (multicolored signal deep to a stone) 2
  • Can detect secondary signs: hydronephrosis, perinephric fluid

Key caveat: While ultrasound has lower sensitivity than CT, it effectively identifies clinically significant stones and complications without radiation exposure. The lower sensitivity primarily affects detection of very small stones that may pass spontaneously.

When to Proceed to CT Imaging

Non-contrast CT abdomen/pelvis should follow ultrasound when 1, 2:

  • Ultrasound is inconclusive or negative despite high clinical suspicion
  • Detailed stone characterization is needed (size, location, density, composition)
  • Treatment planning requires precise measurements
  • Patient has fever, solitary kidney, or diagnostic uncertainty

CT Performance and Technique

The ACR Appropriateness Criteria (2023) designate non-contrast CT as the reference standard with 2:

  • Sensitivity: 97%
  • Specificity: 95-96%
  • Virtually all renal calculi are radiopaque on CT

Use low-dose CT protocol (<3 mSv) which maintains 2:

  • Pooled sensitivity: 97%
  • Pooled specificity: 95%
  • Equivalent stone measurements compared to standard-dose CT

Imaging Tests to Avoid

Do NOT order CT with IV contrast as initial testing 2:

  • Enhancing renal parenchyma obscures stones in the collecting system
  • Only 81% sensitive for detecting all stones (vs. 97% for non-contrast)
  • Contrast is "usually not appropriate as a first-line test" per ACR guidelines

Plain radiography (KUB) has limited utility 1:

  • Sensitivity only 44-77%
  • Cannot detect radiolucent stones (uric acid)
  • May help differentiate radioopaque vs. radiolucent stones if obtained

MRI/MRU is not indicated for routine stone diagnosis 2:

  • Limited stone detection capability (50% sensitivity in one study)
  • Reserved for pregnant patients or when CT/ultrasound contraindicated

Essential Laboratory Testing

Beyond imaging, obtain 1:

  • Urinalysis (dipstick for hematuria, infection)
  • Blood tests: creatinine, uric acid, ionized calcium, sodium, potassium
  • Blood cell count and CRP (to assess for infection/sepsis)

Critical red flags requiring immediate evaluation 1:

  • Fever (suggests infected obstructed system—urologic emergency)
  • Solitary kidney
  • Uncontrolled pain despite analgesia
  • Acute kidney injury

Clinical Algorithm

  1. Start with ultrasound for initial diagnosis in this 74-year-old patient
  2. If ultrasound shows stone or hydronephrosis: Proceed based on clinical presentation and stone characteristics
  3. If ultrasound negative but high suspicion persists: Order low-dose non-contrast CT
  4. If stone confirmed: Obtain stone analysis if passed, perform metabolic evaluation for recurrence risk 1

This stepwise approach balances diagnostic accuracy with radiation safety, particularly important in older adults who may develop recurrent stones requiring serial imaging over their lifetime.

Related Questions

What are the pertinent positive findings that support a diagnosis of nephrolithiasis?
How should I manage a 77-year-old woman with unknown renal and hepatic function and a history of nephrolithiasis who presents with continuous urinary urgency, scant urine output, and dysuria?
Which laboratory tests are indicated for a patient with a history of nephrolithiasis?
What screening questions should be asked when evaluating a patient for suspected kidney stones (nephrolithiasis)?
What are the definition, etiology, clinical symptoms, and diagnostic approach for renal calculi (kidney stones)?
How should I manage a patient with elevated serum PFAS (per‑ and polyfluoroalkyl substances) levels: total 166.64 ng/mL; PFHxS (perfluorohexane sulfonic acid) 43 ng/mL; linear PFOA (perfluorooctanoic acid) 2.89 ng/mL; PFDA (perfluorodecanoic acid) 0.12 ng/mL; linear PFOS (perfluorooctane sulfonic acid) 78.48 ng/mL; branched PFOS (perfluorooctane sulfonic acid) 41.61 ng/mL; PFNA (perfluorononanoic acid) 0.29 ng/mL?
Can a 50-year-old male receiving avelumab (avelumab) for cancer treatment undergo dental implant placement?
What is the 4T score in heparin‑induced thrombocytopenia (HIT)?
How should piperacillin‑tazobactam be dosed in adults based on renal function (GFR or creatinine clearance)?
What are the indications and technique for placing an external ventricular drain?
What is the recommended treatment for community-acquired pneumonia in a cancer patient, including both neutropenic and non-neutropenic scenarios?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.